Compliant response management for life sciences
Pharmaceutical companies, biotech firms, medical device manufacturers, and CROs face response volume from investors, partners, regulators, and clinical research stakeholders. RocketDocs is built with workflows aligned to 21 CFR Part 11 expectations: immutable audit trails, structured electronic approvals, and full history export. Private AI keeps your IP inside your environment.
- 50%
- faster RFP turnaround
- 2x
- capacity per responder
- 95%
- content reuse from approved library
- 100%
- compliant and audit-ready
Why life sciences needs a different platform
The IP is the company
Life sciences has the highest compliance bar of any industry RocketDocs serves. The intellectual property is the company. Pre-clinical data, clinical trial designs, manufacturing process specifications, regulatory submission strategies, and licensing economics all live inside the response content. Sending any of it through a third-party AI provider is not a question of compliance. It is a question of viability.
RocketDocs is built for that bar. RocketDocs generative AI engine runs on Llama 3.3 hosted inside our environment, with no data flow to any external model provider. Audit trails are immutable. Approvals are structured for 21 CFR Part 11-aligned workflows. The same platform deployed at financial services firms whose customers have been auditing them for thirty years now serves life sciences firms whose customers are the FDA.
Life sciences use cases
Every response pattern from investor DDQ to CRO qualification
Investor and partner DDQs
Pharma and biotech firms respond to investor DDQs from venture capital, private equity, sovereign wealth funds, and strategic partners. The questionnaires are deep, the data is sensitive, and the cadence is recurring across the financing lifecycle.
Clinical research partnership RFPs
CROs, sponsors, and academic medical centers exchange RFPs as part of clinical research partnership formation. RocketDocs handles the operational, clinical, and regulatory content these proposals require.
Vendor due diligence
Life sciences companies conduct extensive vendor due diligence on suppliers, CROs, manufacturers, and service providers. The same platform handles both directions: responding to vendor questionnaires from your partners and running vendor management programs internally.
BD&L proposals
Business development and licensing proposals communicate data, terms, and structure of potential deals. RocketDocs supports BD&L workflows with multi-product library structure and structured approval gates.
CRO and supplier qualification
Sponsor companies qualify CROs and suppliers through detailed questionnaires. CROs and suppliers respond to those questionnaires across multiple sponsors with overlapping but not identical content. RocketDocs handles both sides with the same platform.
Pharmacovigilance reporting
Pharmacovigilance teams maintain recurring reporting structures and respond to safety database questionnaires from regulators and partners. The library structure supports the recurring nature of these reports.
Quality management questionnaires
Quality systems audits, GxP qualification questionnaires, and post-marketing surveillance reporting all flow through structured response patterns that RocketDocs supports.
21 CFR Part 11-aligned workflows
Workflows aligned to 21 CFR Part 11 expectations
21 CFR Part 11 governs electronic records and electronic signatures in FDA-regulated environments. RocketDocs is built with workflow patterns that align to the regulation's expectations.
- Immutable audit trails: every action logged, with timestamp, user, and content fingerprint, exportable for inspection
- Structured electronic approvals: approval gates with action permissions per stage, supporting the controls 21 CFR Part 11 requires
- Full export history: every document has audit trails with version traceability
- Validated change control patterns: content change history with diff tracking, supporting the change control documentation FDA-regulated environments require
- Granular permissions: minimum-necessary access enforced at every level
Note that 21 CFR Part 11 alignment is a customer-led validation activity. RocketDocs supports the workflows. Customers conduct their own validation against their internal compliance frameworks.
Compliance frameworks
The frameworks life sciences answers to
- 21 CFR Part 11: workflow alignment for electronic records and electronic signatures
- ICH GCP: good clinical practice alignment for clinical research workflows
- GxP (GMP, GLP, GCP, GDP): general good practice alignment patterns
- EU MDR / IVDR: medical device regulation support for device manufacturers
- FDA submission support patterns: structured content for INDs, NDAs, BLAs, and 510(k) submissions
- EMA alignment: European Medicines Agency reporting structures
- PMDA alignment: Japan Pharmaceuticals and Medical Devices Agency reporting
- SOC 2 Type II and ISO 27001: supporting your own customer and partner security responses
Multi-product portfolio support
Different products, different evidence, shared resources where they apply
Most life sciences firms have multiple products at different stages: commercial, late-stage clinical, early-stage clinical, and pre-clinical. Different products have different evidence, different regulatory paths, and different IP boundaries. RocketDocs library structure supports per-product content with shared resources where applicable and segregation where IP boundaries demand it.
A multi-therapeutic-area pharma company answers DDQs differently for oncology, cardiovascular, immunology, and CNS programs. RocketDocs library structure supports therapeutic area-level customization within a product, with nearest neighbor search that respects the boundaries between TAs.
What life sciences teams get
Everything life sciences teams actually need
- Private AI (Llama 3.3, hosted privately): your IP, clinical data, and regulatory strategies never leave your environment
- Office-native LaunchPad: writers work in Microsoft Word and Excel
- Multi-product library structure: per-product content with shared library or strict segregation
- 21 CFR Part 11-aligned audit trail and approval workflows
- Custom workflows and approval gates: configurable for investor DDQs, partner RFPs, vendor qualification, and clinical research workflows
- Granular permissions: minimum-necessary access enforced at user, role, group, library, and project level
- Salesforce integration: bidirectional sync where life sciences firms run Salesforce for BD pipeline
What customers say
Trusted by the teams whose responses cannot be wrong
The tool itself is very simple and direct. I've trained a lot of people on this and they're like, that's all I have to do? It's the way that RocketDocs works with Word. It's very similar to what they're used to. It's very user friendly.
RocketDocs has competitors in the space. But none of them can do what RapidDocs does. I haven't found any that are as good in product suite. So RapidDocs, from my perspective, is pretty unique. It's a great tool. It can save you time. It can help you to do things a lot easier.
Problems are the same for all RFP teams: finding the correct data at the right time, and organizing data into useful libraries and subtopics. RocketDocs allows us to manage more than 10 different lines of business and keep our data organized and structured.
After over 20 years of using different RFP database management systems, I am impressed with the usability and ease of organization in the system. The speed with which my team can locate and update responses is impressive.
Cycle time on enterprise DDQs dropped from six weeks to under two. The private-AI architecture is the only reason our security team ever signed off on adding generative AI to the response workflow at all.
We run all of our institutional questionnaire responses through RocketDocs. Multi-affiliate library structure handles our three lines of business cleanly; SME assignment and review cycles keep content accurate without anyone having to babysit it.
The Excel multi-tab handling is the feature that closed it for us. SIG Lite, SIG Core, CAIQ, our own customer questionnaires — all multi-tab, all native. The other platforms we evaluated either flattened the tabs or charged extra for the capability.
The audit trail is what finally got us off the spreadsheet-and-email pattern. When 21 CFR Part 11 reviewers ask who approved each answer and when, we have a real answer instead of digging through Slack.
FAQ
Frequently asked questions
Is RocketDocs 21 CFR Part 11 compliant?
RocketDocs is designed with workflow patterns that align to 21 CFR Part 11 expectations: immutable audit trails, structured electronic approvals, and exportable audit history. 21 CFR Part 11 compliance is a customer-led validation activity. The platform supports the workflows. Customers conduct their own validation against their internal compliance frameworks.
Will my IP, clinical data, or regulatory strategies ever be sent to OpenAI or Anthropic?
No. RocketDocs private generative AI runs on Llama 3.3 hosted inside the RocketDocs environment. Your IP, clinical data, regulatory strategies, and other proprietary information never leave your environment.
Does RocketDocs support FDA submission preparation?
RocketDocs supports the content management and response workflows that contribute to FDA submission preparation, including structured content for INDs, NDAs, BLAs, and 510(k) submissions. The platform is not an electronic Common Technical Document (eCTD) system. It is a response management platform whose content can feed into your existing submission workflow.
Can different products and therapeutic areas have different content libraries?
Yes. Multi-product and multi-therapeutic-area support is a default. Each product or TA can have its own library, its own workflows, and its own SMEs, with cross-product content reuse configurable based on your firm's policies.
How does RocketDocs handle CRO and supplier qualification?
Both directions are supported. Sponsors use RocketDocs to qualify CROs and suppliers through structured questionnaires. CROs and suppliers use RocketDocs to respond to those questionnaires across multiple sponsors. The platform handles the workflow on either side.
Does RocketDocs integrate with our existing electronic Common Technical Document (eCTD) system?
RocketDocs is not an eCTD system. The platform integrates with eCTD systems through the Open API for content workflow handoffs, where customers want to maintain content in RocketDocs and submit through their existing eCTD platform.
How long does implementation take for a life sciences company?
Most life sciences deployments are live within four to eight weeks for the primary use case. Multi-product, multi-TA pharma companies with complex 21 CFR Part 11 validation requirements may take longer because the configuration and customer-led validation are deeper.
Ready to see RocketDocs for life sciences?
A specialist will walk you through a configuration tailored to your firm's structure, with multi-product library, 21 CFR Part 11-aligned workflows, and private AI architecture demonstrated end to end.